The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

Helps 68% of Patients: Experimental Coronavirus Medication Tested in the US

According to new data based on patient observations, more than two-thirds of seriously ill patients with COVID-19 improved after treatment with Remdesivir, an experimental drug developed by California-based Gilead Sciences Inc. Writes about it New York Post.

Photo: Shutterstock

Analysis published New England Medical Journaldoes not detail what other treatments the 61 hospitalized patients received, and data for eight of them were not included - in one case due to dosing error.

The author of the article called the results “encouraging,” but warned that it was difficult to interpret the results because they did not include comparison with the control group, as would be the case in a randomized clinical trial. In addition, the number of patients was small, the details disclosed were limited, and the observation time was relatively short.

The study included patients in the United States, Europe, Canada, and Japan who received a 10-day course of intravenous Remdesivir.

Before treatment, 30 patients were on a ventilator, and four were connected to a machine that passes the patient's blood through an artificial oxygenator.

After completing the course of treatment with Remdesivir and observation for 18 days, 36 patients, or 68%, showed a significant improvement. More than half of the 30 patients who were on ventilators at the start of the study were able to breathe on their own. 25 patients, or 47%, were discharged from the hospital. Seven patients, 13% of the total number studied, died.

Twelve patients, 23%, had serious side effects, including multiple organ dysfunction syndrome, septic shock, and acute kidney damage.

“We look forward to seeing the results of controlled clinical trials to confirm our findings,” wrote Dr. Jonathan Grain, lead article author and director of epidemiology at Cedars-Sinai Medical Center in Los Angeles.

On the subject: Can disposable gloves protect against coronavirus: doctors explain

There are currently no approved treatments or prophylactic vaccines against COVID-19, a respiratory disease caused by the new coronavirus, which has killed more than 117 people worldwide.

Gilead sharply curtailed its Remdesivir program in March and is conducting its own clinical trials of the antiviral drug, with results expected in the coming weeks. Researchers in China and the US National Institutes of Health are also testing Remdesivir on COVID-19 patients.

Miscellaneous In the U.S. treatment coronavirus Special Projects

Read also on ForumDaily:

Can disposable gloves protect against coronavirus: doctors explain

How to cook safely during a pandemic: UNICEF recommendations

Conspiracy theories from the Russian media: what did they come up with about coronavirus

'And then the phone fell into the bath': why it is so difficult to work from home during quarantine

Which masks are effective against coronavirus and how can they be replaced in case of deficiency

Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the "Display Priority" option and read us first. And don't forget to subscribe to ForumDaily Woman and ForumDaily New York - there you will find a lot of interesting and positive information.



1048 requests in 2,076 seconds.